VIR Vir Biotechnology Inc
5,926
$11.37
$1.16
(11.36%)
| Watchers | 5,926 |
| 52-Wk Low | $7.61 |
| 52-Wk High | $27.48 |
| Market Cap | $1.55B |
| Volume | 1.63M |
| 52-Wk High | $27.48 |
| 52-Wk Low | $7.61 |
Multiple Abstracts Highlighting Vir Biotechnologys Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024Business Wire • about 18 hours ago
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting new data from the Companys chronic hepatitis delta and chronic hepatitis B programs have been accepted for...
Share to Feed
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the EASL Congress has changed the Companys Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The...
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies Brii Biosciences Announces Two...
Latest Ratings for VIR
DateFirmActionFromTo Mar 2022BairdUpgradesUnderperformNeutral Dec 2021BairdDowngradesNeutralUnderperform Dec 2021HC Wainwright & Co.MaintainsBuy
View More Analyst...
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024. We are excited to share important data from our...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities...
Vir Biotechnology, Inc. (Vir or the Company, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the Board) at its upcoming...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2024, on May 2, 2024. The Company...
Related Stocks: VIR...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Free Report) CFO Sung Lee sold 6,008 shares of Vir Biotechnology stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at...